Home
IMRN
IMRN News

Latest Immuron Limited (IMRN) News on September 15, 2025

Immuron - FY25 global sales exceed projection, up 49% on prior year

GlobeNewswire

2 months ago

Immuron - FY25 global sales exceed projection, up 49% on prior year

Immuron Letter to Shareholders: Projects Update

GlobeNewswire

4 months ago

Immuron Letter to Shareholders: Projects Update

Immuron Travelan® highest sales in history

GlobeNewswire

5 months ago

Immuron Travelan® highest sales in history

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

GlobeNewswire

6 months ago

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now

GlobeNewswire

7 months ago

Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now

Immuron Travelan® continued strong sales growth

GlobeNewswire

8 months ago

Immuron Travelan® continued strong sales growth

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

GlobeNewswire

8 months ago

Immuron Announces New Research Collaboration targeting Antimicrobial Resistance

Immuron Announces Travelan® Clinical Trial Update

GlobeNewswire

8 months ago

Immuron Announces Travelan® Clinical Trial Update

Hartshead Resources And 2 Other Promising Penny Stocks On The ASX

Simply Wall St.

8 months ago

Hartshead Resources And 2 Other Promising Penny Stocks On The ASX

UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing

GlobeNewswire

9 months ago

UPDATE: Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing

Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th

GlobeNewswire

9 months ago

Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

ACCESSWIRE

9 months ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th

GlobeNewswire

9 months ago

Small Cap Growth Virtual Investor Conference Agenda Announced for December 5th

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

GlobeNewswire

9 months ago

Immuron CEO, Steven Lydeamore to Present at the Small Cap Growth Virtual Investor Conference December 5th

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

GlobeNewswire

10 months ago

Immuron CEO, Steven Lydeamore presentation to 21st Virtual Investor Summit Microcap Event

ACCESSWIRE

10 months ago

Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

GlobeNewswire

a year ago

Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference

Immuron Travelan® continued strong sales growth

GlobeNewswire

a year ago

Immuron Travelan® continued strong sales growth

MT Newswires

a year ago

Immuron Says US Navy Completes Interim Analysis of Drug for Campylobacter, Enterotoxigenic Escherichia Coli

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

GlobeNewswire

a year ago

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Immuron Full Year 2024 Earnings: AU$0.03 loss per share (vs AU$0.017 loss in FY 2023)

Simply Wall St.

a year ago

Immuron Full Year 2024 Earnings: AU$0.03 loss per share (vs AU$0.017 loss in FY 2023)

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 75 Day 1 on September 25 Register Now

MT Newswires

a year ago

Immuron Plans Phase 2 Trial for IMM-529 Following Positive US FDA Feedback

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

GlobeNewswire

a year ago

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now

US DoD grants $2.3m to Immuron for military version of anti-diarrhoeal Travelan

Pharmaceutical Technology

a year ago

US DoD grants $2.3m to Immuron for military version of anti-diarrhoeal Travelan

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

GlobeNewswire

a year ago

Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

GlobeNewswire

a year ago

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

GlobeNewswire

a year ago

Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

Immuron announces record Travelan® sales globally, Australia and USA

GlobeNewswire

a year ago

Immuron announces record Travelan® sales globally, Australia and USA

MT Newswires

a year ago

Immuron Files for Mixed-Shelf Offering; Plans to Raise $2M Through At-The-Market Equity Sale

MT Newswires

a year ago

Immuron Requests Meeting With FDA for Potential Colon Infection Therapy

Immuron requests pre-IND meeting for IMM-529 with FDA filing

GlobeNewswire

a year ago

Immuron requests pre-IND meeting for IMM-529 with FDA filing

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

GlobeNewswire

a year ago

Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference

Immuron Board Changes

GlobeNewswire

a year ago

Immuron Board Changes

Immuron CEO Steven Lydeamore to present at Peak Sky High

GlobeNewswire

a year ago

Immuron CEO Steven Lydeamore to present at Peak Sky High

Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now

GlobeNewswire

a year ago

Presenting on the Emerging Growth Conference 70 Day 1 on May 8 Register Now

Immuron Limited to Present at the Emerging Growth Conference

GlobeNewswire

a year ago

Immuron Limited to Present at the Emerging Growth Conference

Immuron Director Resignation

GlobeNewswire

a year ago

Immuron Director Resignation

Immuron to host Live Virtual Event

GlobeNewswire

a year ago

Immuron to host Live Virtual Event

Immuron Travelan® sales continued strong growth

GlobeNewswire

a year ago

Immuron Travelan® sales continued strong growth

We're Not Very Worried About Immuron's (ASX:IMC) Cash Burn Rate

Simply Wall St.

2 years ago

We're Not Very Worried About Immuron's (ASX:IMC) Cash Burn Rate

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

GlobeNewswire

2 years ago

Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US

Immuron Presentation Australian Biologics Festival 2024

GlobeNewswire

2 years ago

Immuron Presentation Australian Biologics Festival 2024

Immuron achieves record Travelan® sales

GlobeNewswire

2 years ago

Immuron achieves record Travelan® sales

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

GlobeNewswire

2 years ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

GlobeNewswire

2 years ago

Lakeshore Acquisition II Corp. Announces Effectiveness of Registration Statement and Date for General Meeting to Approve Proposed Business Combination with Nature’s Miracle

AmeriServ Financial's (NASDAQ:ASRV) Dividend Will Be $0.03

Simply Wall St.

2 years ago

AmeriServ Financial's (NASDAQ:ASRV) Dividend Will Be $0.03

Ahead of Stellar Bancorp (STEL) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

Zacks

2 years ago

Ahead of Stellar Bancorp (STEL) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

We Think Allied Gaming & Entertainment (NASDAQ:AGAE) Can Afford To Drive Business Growth

Simply Wall St.

2 years ago

We Think Allied Gaming & Entertainment (NASDAQ:AGAE) Can Afford To Drive Business Growth

5E Advanced Materials Selects EPC Contractor Fluor Corporation For Process Engineering Work on FEL-2

GlobeNewswire

2 years ago

5E Advanced Materials Selects EPC Contractor Fluor Corporation For Process Engineering Work on FEL-2

Reuters

2 years ago

PRESS DIGEST- Wall Street Journal - Jan 19

Mesa Air Group Strikes Deal With United Airlines to Improve Liquidity

The Wall Street Journal

2 years ago

Mesa Air Group Strikes Deal With United Airlines to Improve Liquidity

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

PR Newswire

2 years ago

Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering

CPSI Announces Divestment of American HealthTech to PointClickCare

Business Wire

2 years ago

CPSI Announces Divestment of American HealthTech to PointClickCare

SOS Ltd. Announces Launch of Additional 1,500 mining rigs at its Super-Computing Center in Texas

PR Newswire

2 years ago

SOS Ltd. Announces Launch of Additional 1,500 mining rigs at its Super-Computing Center in Texas

Immuron achieves record half yearly Travelan® sales

GlobeNewswire

2 years ago

Immuron achieves record half yearly Travelan® sales

Meta Materials Announces Proposed SEC Settlement

ACCESSWIRE

2 years ago

Meta Materials Announces Proposed SEC Settlement

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships

Business Wire

2 years ago

Grove Collaborative Surpasses 15 Million Pounds of Nature-Bound Single-Use Plastic Collected Through Plastic Neutrality Commitment & Partnerships

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

GlobeNewswire

2 years ago

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

Culp, Inc. to Participate in Water Tower Research Furniture/Furnishings Virtual Conference 2024

Business Wire

2 years ago

Culp, Inc. to Participate in Water Tower Research Furniture/Furnishings Virtual Conference 2024

Fury Reviews 2023 Achievements and Appoints CFO

ACCESSWIRE

2 years ago

Fury Reviews 2023 Achievements and Appoints CFO

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

GlobeNewswire

2 years ago

Veru Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business

GlobeNewswire

2 years ago

DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business

NLS Pharmaceutics CEO Issues Letter to Shareholders

ACCESSWIRE

2 years ago

NLS Pharmaceutics CEO Issues Letter to Shareholders

Cenntro Electric Group Receives EU Compliance Certifications R155 and R156

Business Wire

2 years ago

Cenntro Electric Group Receives EU Compliance Certifications R155 and R156

MultiMetaVerse Announces Release of Restricted Closing Payment Shares

PR Newswire

2 years ago

MultiMetaVerse Announces Release of Restricted Closing Payment Shares

Immuron Clinical Trials Update

GlobeNewswire

2 years ago

Immuron Clinical Trials Update

Servotronics Provides Investor Update on Strategic Vision to Maximize Long-Term Shareholder Value and Initial 2024 Outlook

PR Newswire

2 years ago

Servotronics Provides Investor Update on Strategic Vision to Maximize Long-Term Shareholder Value and Initial 2024 Outlook

OKO Digital Announces Strategic Partnership With Loop Media

PR Newswire

2 years ago

OKO Digital Announces Strategic Partnership With Loop Media

TMC Subsidiary NORI Shares Preliminary Findings on Environmental Impacts of Pilot Nodule Collection System Test

GlobeNewswire

2 years ago

TMC Subsidiary NORI Shares Preliminary Findings on Environmental Impacts of Pilot Nodule Collection System Test

BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today

GlobeNewswire

2 years ago

BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today

SPI Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

ACCESSWIRE

2 years ago

SPI Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

180 Degree Capital Corp. Notes Appointment of Kevin M. Rendino to the Board of Directors of Its Portfolio Company, Synchronoss Technologies, Inc.

GlobeNewswire

2 years ago

180 Degree Capital Corp. Notes Appointment of Kevin M. Rendino to the Board of Directors of Its Portfolio Company, Synchronoss Technologies, Inc.

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

GlobeNewswire

2 years ago

Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study

PodcastOne (Nasdaq: PODC) to Present at NobleCon19 - Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference

GlobeNewswire

2 years ago

PodcastOne (Nasdaq: PODC) to Present at NobleCon19 - Noble Capital Markets' Nineteenth Annual Emerging Growth Equity Conference

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

GlobeNewswire

2 years ago

Immuron CEO, Steven Lydeamore Investor Webinar Presentation

Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

Business Wire

2 years ago

Kezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

GlobeNewswire

2 years ago

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

7 A-Rated Retirement Stocks for Your November Buy List

InvestorPlace

2 years ago

7 A-Rated Retirement Stocks for Your November Buy List

180 Degree Capital Corp. (NASDAQ:TURN) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

180 Degree Capital Corp. (NASDAQ:TURN) Q3 2023 Earnings Call Transcript

CXApp Inc. (Nasdaq:CXAI) Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

ACCESSWIRE

2 years ago

CXApp Inc. (Nasdaq:CXAI) Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

Nephros Announces Results for Quarter Ended September 30, 2023

GlobeNewswire

2 years ago

Nephros Announces Results for Quarter Ended September 30, 2023

Surrozen Provides Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Surrozen Provides Third Quarter 2023 Financial Results

Sun Country Airlines (SNCY) Q3 2023 Earnings Call Transcript

Motley Fool

2 years ago

Sun Country Airlines (SNCY) Q3 2023 Earnings Call Transcript

Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration

GlobeNewswire

2 years ago

Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche Collaboration

Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting

GlobeNewswire

2 years ago

Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting

Share on Social Networks: